Viemed Healthcare Share Price (NASDAQ: VMD)

$7.3

▲

0.25

(3.55%)

Live

Last updated on August 23, 2025 at 12:41 AM IST

$₹

Check the interactive Viemed Healthcare Stock chart to analyse performance

Viemed Healthcare stock performance

as on August 23, 2025 at 12:41 AM IST

Today's Low:$7.12
Today's High:$7.33
$7.30
2.47%
Downside
Day's Volatility :2.86%
Upside
0.41%
52 Weeks Low:$5.93
52 Weeks High:$9.81
$7.30
18.77%
Downside
52 Weeks Volatility :39.55%
Upside
25.59%

Viemed Healthcare Stock Returns

Period	Viemed Healthcare Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	10.44%	5.0%	0.0%
6 Months	-8.87%	-6.4%	0.0%
1 Year	-1.8%	-11.5%	0.0%
3 Years	17.38%	4.5%	-7.7%

Viemed Healthcare Inc Key Stats

Check Viemed Healthcare key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$7.05
Open	$6.92
Today's High	$7.33
Today's Low	$7.12
Market Capitalization	$273.4M
Today's Volume	$285.2K
52 Week High	$9.81
52 Week Low	$5.93
Revenue TTM	$240.9M
EBITDA	$42.9M
Earnings Per Share (EPS)	$0.34
PE Ratio	20.74
Profit Margin	5.8%
Quarterly Earnings Growth YOY	1.11%
Return On Equity TTM	10.87%

Stock Returns calculator for Viemed Healthcare Stock including INR - Dollar returns

The Viemed Healthcare stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Viemed Healthcare investment value today

Current value as on today

₹1,05,389

Returns

₹5,389

(+5.39%)

Returns from Viemed Healthcare Stock

₹1,108 (+1.11%)

Dollar Returns*

₹4,281 (+4.28%)

Indian investors sentiment towards Viemed Healthcare Stock

-80%

Period: Jul 22, 2025 to Aug 21, 2025. Change in 30 Days versus previous period

Search interest for Viemed Healthcare Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Viemed Healthcare Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
9.32%
Thrivent Financial For Lutherans
5.54%
Forager Capital Management, LLC
5.51%
Vanguard Group Inc
4.69%
Wasatch Advisors LP
3.37%
Kent Lake PR LLC
3.04%

Analyst Recommendation on Viemed Healthcare Stock

Rating

Trend

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Viemed Healthcare(by analysts ranked 0 to 5 stars)

Viemed Healthcare Share Price Target

What analysts predicted

Upside of 78.08%

Target:

$13.00

Current:

$7.30

Viemed Healthcare share price target is $13.00, a slight Upside of 78.08% compared to current price of $7.30 as per analysts' prediction.

Viemed Healthcare Stock Insights

Price Movement
In the last 7 days, VMD stock has moved up by 2.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 59.12M → 63.05M (in $), with an average increase of 6.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 2.62M → 3.15M (in $), with an average increase of 16.9% per quarter
VMD vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 32.2% return, outperforming this stock by 34.0%
VMD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 155.0% return, outperforming this stock by 136.6%
Price to Sales
ForVMD every $1 of sales, investors are willing to pay $1.2, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Viemed Healthcare Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$80.3M	↑ 22.96%
Net Income	$8.5M	↓ 16.23%
Net Profit Margin	10.62%	↓ 4.97%

	FY20	Y/Y Change
Revenue	$131.3M	↑ 63.61%
Net Income	$31.5M	↑ 269.85%
Net Profit Margin	24.01%	↑ 13.39%

	FY21	Y/Y Change
Revenue	$117.1M	↓ 10.85%
Net Income	$9.1M	↓ 71.06%
Net Profit Margin	7.8%	↓ 16.21%

	FY22	Y/Y Change
Revenue	$138.8M	↑ 18.6%
Net Income	$6.2M	↓ 31.82%
Net Profit Margin	4.48%	↓ 3.32%

	FY23	Y/Y Change
Revenue	$183.0M	↑ 31.82%
Net Income	$10.2M	↑ 64.63%
Net Profit Margin	5.6%	↑ 1.12%

	FY24	Y/Y Change
Revenue	$224.3M	↑ 22.54%
Net Income	$11.3M	↑ 9.98%
Net Profit Margin	5.02%	↓ 0.58%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$50.6M	↓ 2.97%
Net Income	$1.6M	↓ 53.9%
Net Profit Margin	3.17%	↓ 3.5%

	Q2 FY24	Q/Q Change
Revenue	$55.0M	↑ 8.64%
Net Income	$1.5M	↓ 8.42%
Net Profit Margin	2.67%	↓ 0.5%

	Q3 FY24	Q/Q Change
Revenue	$58.0M	↑ 5.53%
Net Income	$3.9M	↑ 164.17%
Net Profit Margin	6.69%	↑ 4.02%

	Q4 FY24	Q/Q Change
Revenue	$60.7M	↑ 4.64%
Net Income	$4.3M	↑ 11.29%
Net Profit Margin	7.11%	↑ 0.42%

	Q1 FY25	Q/Q Change
Revenue	$59.1M	↓ 2.58%
Net Income	$2.6M	↓ 39.18%
Net Profit Margin	4.44%	↓ 2.67%

	Q2 FY25	Q/Q Change
Revenue	$63.1M	↑ 6.64%
Net Income	$3.2M	↑ 20.27%
Net Profit Margin	5.01%	↑ 0.57%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$56.0M	↑ 15.28%

	FY20	Y/Y Change
Profit	$80.1M	↑ 43.04%

	FY21	Y/Y Change
Profit	$73.4M	↓ 8.36%

	FY22	Y/Y Change
Profit	$84.7M	↑ 15.35%

	FY23	Y/Y Change
Profit	$112.8M	↑ 33.19%

	FY24	Y/Y Change
Profit	$133.2M	↑ 18.11%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$29.8M	↓ 8.45%

	Q2 FY24	Q/Q Change
Profit	$32.5M	↑ 9.1%

	Q3 FY24	Q/Q Change
Profit	$34.4M	↑ 5.71%

	Q4 FY24	Q/Q Change
Profit	$36.1M	↑ 5.14%

	Q1 FY25	Q/Q Change
Profit	$33.3M	↓ 7.91%

	Q2 FY25	Q/Q Change
Profit	$36.4M	↑ 9.31%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$19.1M	↓ 14.67%
Investing Cash Flow	$-12.8M	↑ 141.67%
Financing Cash Flow	$-3.3M	↓ 71.63%

	FY20	Y/Y Change
Operating Cash Flow	$35.1M	↑ 83.95%
Investing Cash Flow	$-8.4M	↓ 34.31%
Financing Cash Flow	$-9.1M	↑ 172.02%

	FY21	Y/Y Change
Operating Cash Flow	$22.5M	↓ 35.93%
Investing Cash Flow	$-19.7M	↑ 134.65%
Financing Cash Flow	$-5.3M	↓ 41.33%

	FY22	Y/Y Change
Operating Cash Flow	$27.7M	↑ 23.36%
Investing Cash Flow	$-24.0M	↑ 21.42%
Financing Cash Flow	$-15.3M	↑ 186.9%

	FY23	Y/Y Change
Operating Cash Flow	$45.2M	↑ 62.94%
Investing Cash Flow	$-52.1M	↑ 117.35%
Financing Cash Flow	$2.8M	↓ 118.51%

	FY24	Y/Y Change
Operating Cash Flow	$39.1M	↓ 13.54%
Investing Cash Flow	$-30.7M	↓ 41.09%
Financing Cash Flow	$-3.7M	↓ 230.54%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$1.2M	↓ 91.7%
Investing Cash Flow	$-5.4M	↓ 36.12%
Financing Cash Flow	$-1.3M	↓ 55.66%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$10.2M	↑ 766.55%
Investing Cash Flow	$-11.2M	↑ 108.15%
Financing Cash Flow	$2.5M	↓ 285.3%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$12.7M	↑ 25.17%
Investing Cash Flow	$-5.0M	↓ 55.5%
Financing Cash Flow	$-5.2M	↓ 310.87%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$15.0M	↑ 17.59%
Investing Cash Flow	$-9.2M	↑ 85.11%
Financing Cash Flow	$404.0K	↓ 107.72%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$2.9M	↓ 80.96%
Investing Cash Flow	$-8.5M	↓ 7.26%
Financing Cash Flow	$-1.7M	↓ 521.78%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$12.3M	↑ 329.36%
Investing Cash Flow	$-1.7M	↓ 79.75%
Financing Cash Flow	$-671.0K	↓ 60.62%

Viemed Healthcare Technicals Summary

Sell

Neutral

Buy

Viemed Healthcare is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Viemed Healthcare Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Viemed Healthcare Inc	9.75%	-8.87%	-1.8%	17.38%	-35.01%
Medtronic Plc	-1.01%	1.27%	3.7%	0.95%	-9.04%
Edwards Lifesciences Corp.	5.6%	10.8%	13.91%	-13.73%	3.19%
Boston Scientific Corp.	-2.37%	0.68%	32.2%	157.48%	170.17%
Stryker Corporation	-4.04%	0.51%	9.69%	83.95%	103.88%
Abbott Laboratories	4.94%	-2.13%	17.79%	24.55%	30.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Viemed Healthcare Inc	20.74	20.74	NA	0.43	0.11	0.06	NA	3.53
Medtronic Plc	25.17	25.17	2.19	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	33.96	33.96	4.86	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	63.13	63.13	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.83	51.83	2.23	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.56	16.56	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Viemed Healthcare Inc	Buy	$273.4M	-35.01%	20.74	5.8%
Medtronic Plc	Buy	$116.7B	-9.04%	25.17	13.63%
Edwards Lifesciences Corp.	Buy	$47.6B	3.19%	33.96	72.96%
Boston Scientific Corp.	Buy	$157.1B	170.17%	63.13	13.55%
Stryker Corporation	Buy	$149.8B	103.88%	51.83	12.25%
Abbott Laboratories	Buy	$229.7B	30.23%	16.56	32.43%

About Viemed Healthcare Inc

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Organization	Viemed Healthcare
Employees	1258
CEO	Mr. Casey Hoyt
Industry	Health Services

Key Management of Viemed Healthcare Inc

Name	Title
Mr. Casey Hoyt	CEO & Director
Mr. Michael B. Moore CRT	President
Mr. Trae Paul Fitzgerald	Chief Financial Officer
Mr. William Todd Zehnder	COO & Director
Mr. Jeremy Trahan	General Counsel & Corporate Secretary
Dr. William Dana Frazier M.D.	Chief Medical Officer & Director
Mr. Jerome Richard Cambre II	Vice President of Sales
Mr. Michael Freeman	Chief Business Development Officer

Important FAQs about investing in VMD Stock from India :

What is Viemed Healthcare share price today?

Viemed Healthcare share price today is $7.30 as on August 23, 2025 at 12:41 AM IST. Viemed Healthcare share today touched a day high of $7.33 and a low of $7.12.

What is the 52 week high and 52 week low for Viemed Healthcare share?

Viemed Healthcare share touched a 52 week high of $9.81 and a 52 week low of $5.93. Viemed Healthcare stock price today i.e. August 23, 2025 at 12:41 AM IST is trending at $7.30, lower by 25.59% versus the 52 week high.

How to invest in Viemed Healthcare Stock (VMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Viemed Healthcare on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Viemed Healthcare Shares that will get you 0.2055 shares as per Viemed Healthcare share price of $7.30 per share as on August 23, 2025 at 12:41 AM IST.

What is the minimum amount required to buy Viemed Healthcare Stock (VMD) from India?

Indian investors can start investing in Viemed Healthcare (VMD) shares with as little as ₹87.521 or $1 (as of August 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Viemed Healthcare stock (as per the Rupee-Dollar exchange rate as on August 22, 2025). Based on Viemed Healthcare share’s latest price of $7.30 as on August 23, 2025 at 12:41 AM IST, you will get 1.3699 shares of Viemed Healthcare. Learn more about fractional shares .

What are the returns that Viemed Healthcare has given to Indian investors in the last 5 years?

Viemed Healthcare stock has given -35.01% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?